|
BOTOX®
Cosmetic News
As
the economy slows, Botox popularity grows. Can it be true
that people are turning to Botox to cure their recessionary
blues?
Can it
be true that people are turning to Botox to cure their recessionary
blues? That’s a plausible explanation for the latest
statistics from the American Society for Dermatological Surgery.
Allergan
CEO says Company on Growth Path
David Pyott, chairman and CEO of Irvine-based Allergan Inc.,
said his company is positioned to grow despite the economic
downturn, because it has plenty of cash, product diversity
and new products in the pipeline. He sat for an interview
this morning. Some excerpts.
Botox:
Poison or Panacea: Dr. Sanjay Gupta for CNN
"Can you steal some for me?" asked my 81-year-old
grandmother when she heard I was reporting on Botox. It's
a hot commodity even to my old-fashioned granny who has never
driven a car nor touched a computer in her life. "It's
like magic," she said. Apparently,
she's not alone in her lust and awe. Using the substance for
facial lines is this country's most popular cosmetic procedure,
according to the latest numbers from the American Society
of Plastic Surgeons. In just five years, the number of aesthetic
procedures has quintupled.
Botox
Patients are Getting Younger
Botox patients are getting younger, according to a market
information report by Millenium Research Group. The
market researchers say that the 26- to 35-year-old age group
will comprise more than 20 percent of Botox patients this
year, according to an online news item from Cosmetic Surgery
Times magazine. That’s an increase from 7 percent last
year, the researchers said.
Botox
for Beginners
I bet you’ve thought about it, “What could Botox
do for me?” What’s stopping you from giving it try?
If you fear that you’ll end up looking “frozen”
like some of those Hollywood celebrities who dead-pan it thru
the red carpet or what your friends will think; don’t.
F.D.A.
Approves Allergan Drug for Fighting Wrinkles
Botox, a wildly popular treatment for wrinkles, was approved
yesterday by the Food and Drug Administration for cosmetic
use to treat frown lines.
The approval
permits Allergan, the maker of Botox, to begin a multimillion-dollar
marketing campaign aimed at doctors and consumers. Until now,
because Botox had received regulatory approval as a treatment
only for eye spasms and other neurological disorders, the
drug's use as a cosmetic treatment has grown largely through
word of mouth.
|
